NasdaqCM - Nasdaq Real Time Price USD

Alpha Tau Medical Ltd. (DRTSW)

Compare
0.2510
+0.0410
+(19.52%)
At close: January 10 at 4:00:00 PM EST
0.2559
+0.00
+(1.95%)
After hours: 7:56:12 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Uzi Sofer CEO & Chairman 630k -- 1970
Mr. Raphi Levy Chief Financial Officer 424k -- 1985
Mr. Amnon Gat Chief Operations Officer 340k -- 1975
Mr. Peter M. Melnyk Chief Commercial Officer 376k -- 1962
Dr. Robert B. Den M.D. Chief Medical Officer & Member of Scientific Advisory Board 401k -- 1979
Mr. Ronen Segal Chief Technology Officer 380k -- 1973
Prof. Yona Keisari Chief Scientific Officer & Member of Scientific Advisory board -- -- 1947
Ms. Rebecca Becker Vice President of legal -- -- --
Prof. Itzhak Kelson Chief Physics Officer & Member of Scientific Advisory Board -- -- 1940
Ms. Yael Zeiger Corporate Controller -- -- 1983

Alpha Tau Medical Ltd.

Kiryat Hamada Street 5
Jerusalem, 9777605
Israel
972 3 577 4115 https://www.alphatau.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
121

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Corporate Governance

Alpha Tau Medical Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers